Zdrowie i gospodarka · 06/05/2015

FDA Releases Guidance for Industry on Administrative Applications and Phased Review Process for New Animal Drug Development

The Food and Drug Administration (FDA) has made available a guidance document (GFI #132) outlining the process for submitting administrative applications for new animal drugs, including the phased review process for reviewing application-level information during the investigational period.